BMC Cancer,2010年
Guang He, Lin He, Zhihai Peng, Guoyin Feng, Yifeng Xu, Yanzeng Xiao, Jinfen Wang, Quan Wang, Fengping Yang, Jue Ji, Tao Li, Ti Wang, Peng Chen, Qingzhu Zhao, Baocheng Liu, Xingwang Li, Lei Wang, Yang Wang
英文
Background
Genetic factors related to the regulation of apoptosis in schizophrenia patients may be involved in a reduced vulnerability to cancer. XRCC4 is one of the potential candidate genes associated with schizophrenia which might induce colorectal cancer resistance.
Methods
To examine the genetic association between colorectal cancer and schizophrenia, we analyzed five SNPs (rs6452526, rs2662238, rs963248, rs35268, rs2386275) covering ~205.7 kb in the region of XRCC4.
Results
We observed that two of the five genetic polymorphisms showed statistically significant differences between 312 colorectal cancer subjects without schizophrenia and 270 schizophrenia subjects (rs6452536, p = 0.004, OR 0.61, 95% CI 0.44-0.86; rs35268, p = 0.028, OR 1.54, 95% CI 1.05-2.26). Moreover, the haplotype which combined all five markers was the most significant, giving a global p = 0.0005.
Conclusions
Our data firstly indicate that XRCC4 may be a potential protective gene towards schizophrenia, conferring reduced susceptibility to colorectal cancer in the Han Chinese population.
BMC Cancer,2010年
Guang He, Lin He, Zhihai Peng, Guoyin Feng, Yifeng Xu, Yanzeng Xiao, Jinfen Wang, Quan Wang, Fengping Yang, Jue Ji, Tao Li, Ti Wang, Peng Chen, Qingzhu Zhao, Baocheng Liu, Xingwang Li, Lei Wang, Yang Wang
英文
Background
Genetic factors related to the regulation of apoptosis in schizophrenia patients may be involved in a reduced vulnerability to cancer. XRCC4 is one of the potential candidate genes associated with schizophrenia which might induce colorectal cancer resistance.
Methods
To examine the genetic association between colorectal cancer and schizophrenia, we analyzed five SNPs (rs6452526, rs2662238, rs963248, rs35268, rs2386275) covering ~205.7 kb in the region of XRCC4.
Results
We observed that two of the five genetic polymorphisms showed statistically significant differences between 312 colorectal cancer subjects without schizophrenia and 270 schizophrenia subjects (rs6452536, p = 0.004, OR 0.61, 95% CI 0.44-0.86; rs35268, p = 0.028, OR 1.54, 95% CI 1.05-2.26). Moreover, the haplotype which combined all five markers was the most significant, giving a global p = 0.0005.
Conclusions
Our data firstly indicate that XRCC4 may be a potential protective gene towards schizophrenia, conferring reduced susceptibility to colorectal cancer in the Han Chinese population.